Maze Therapeutics, Inc. Common Stock (MAZE)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 525.32M
P/E Ratio
0.00
Revenue (TTM)
$ 167.5M
Volume
0
52W High
$ 17.00
52W Low
$ 6.71
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
13.1036
200-Day MA
13.1036
52 Week High
17
52 Week Low
6.71
About MAZE
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in .
Employees
125
Headquarters
South San Francisco, CA
CEO
Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D.
Latest News
"Journey Through the Maze: 45 Years of PAC-MAN" opens May 18 at Great Park Gallery - City of Irvine
1 weeks ago • Google News
Navigating the FTA maze - Hindustan Times
4 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg